Provided by Tiger Trade Technology Pte. Ltd.

Amgen

381.50
+4.151.10%
Post-market: 380.50-1.0000-0.26%19:55 EDT
Volume:2.71M
Turnover:1.03B
Market Cap:205.43B
PE:23.70
High:384.61
Open:381.94
Low:376.76
Close:377.35
52wk High:447.03
52wk Low:269.77
Shares:538.48M
Float Shares:536.99M
Volume Ratio:0.79
T/O Rate:0.51%
Dividend:9.80
Dividend Rate:2.57%
EPS(TTM):16.10
EPS(LYR):14.23
ROE:91.47%
ROA:8.67%
PB:17.58
PE(LYR):26.81

Loading ...

Political and General News Events from September 2

Reuters
·
Sep 02

Investors Shrug Off Good News for Heart Patients from New Meds

Dow Jones
·
Sep 02

Vertex Names Jonathan Poole CFO Effective Jan. 1, 2027

Reuters
·
Sep 01

Global Pharma Companies That Have Publicly Announced Trump Drug Pricing Agreements

Reuters
·
Sep 01

UK Regulator Suspends Avacopan Vifor for New Patients

MT Newswires Live
·
Sep 01

UK's Mhra : Informed Marketing Authorisation Holder of Decision to Suspend Use, Supply, Sale of Avacopan Vifor for New Patients from 1 September

THOMSON REUTERS
·
Sep 01

Why Is Amgen (AMGN) In Focus After New Repatha Survival Data?

Simply Wall St.
·
Sep 01

Trump Administration Announces Drug Pricing Deals with CSL, Astellas and Others

Reuters
·
Sep 01

Political and General News Events from August 31

Reuters
·
Aug 31

Amgen Says Repatha Cuts Death Risk 20% in High-Risk Patients

MT Newswires Live
·
Aug 31

Amgen Repatha reduces risk of death in high-risk adults for first heart attack

TIPRANKS
·
Aug 31

Amgen's Repatha® Reduces Risk of Death in Patients at High Risk for a First Heart Attack or Stroke

THOMSON REUTERS
·
Aug 31

Amgen Inc. Stock Underperforms Friday When Compared to Competitors

Dow Jones
·
Aug 29

Amgen’s Pediatric Psoriasis Study Wrap-Up: What Apremilast Safety Data Means for Investors

TIPRANKS
·
Aug 29

Political and General News Events from August 28

Reuters
·
Aug 28

Amgen’s AMG 691 Phase 1 Trial Targets Key Growth in Asian Markets

TIPRANKS
·
Aug 28

Analysts Offer Insights on Healthcare Companies: Verrica Pharmaceuticals (VRCA) and Amgen (AMGN)

TIPRANKS
·
Aug 27

HBM Holdings FY26 H1 Profit Falls 11.16% to US$ 64.85 Million; Revenue Rises 20.9% to US$ 122.49 Million

Reuters
·
Aug 27

Amgen, AstraZeneca announce Crossing trial showed ‘meaningful’ improvements

TIPRANKS
·
Aug 27

Amgen, AstraZeneca report CROSSING trial met co-primary and secondary endpoints

TIPRANKS
·
Aug 27